"The
Report Hyperlipidemia Global Clinical Trials Review, H1, 2016
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
GlobalData's
clinical trial report, Hyperlipidemia
Global Clinical Trials Review, H1, 2016"
provides an overview of Hyperlipidemia clinical trials scenario. This
report provides top line data relating to the clinical trials on
Hyperlipidemia. Report includes an overview of trial numbers and
their average enrollment in top countries conducted across the globe.
The report offers coverage of disease clinical trials by region,
country (G7 & E7), phase, trial status, end points status and
sponsor type. Report also provides prominent drugs for in-progress
trials (based on number of ongoing trials). GlobalData Clinical Trial
Reports are generated using GlobalDatas proprietary database - Pharma
eTrack Clinical trials database. Clinical trials are collated from
80+ different clinical trial registries, conferences, journals, news
etc across the globe. Clinical trials database undergoes periodic
update by dynamic process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Download Sample copy of this
Report at: http://www.marketresearchreports.biz/sample/sample/747750
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months.
Reasons to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level.
Table Of Content
Table
of Contents 2
List
of Tables 3
List
of Figures 4
Report
Guidance 5
Clinical
Trials by Region 6
Clinical
Trials and Average Enrollment by Country 7
Top
Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top
Five Countries Contributing to Clinical Trials in Europe 10
Top
Countries Contributing to Clinical Trials in North America 11
Top
Five Countries Contributing to Clinical Trials in Middle East and
Africa 12
Top
Five Countries Contributing to Clinical Trials in Central and South
America 13
Clinical
Trials by G7 Countries: Proportion of Hyperlipidemia to Metabolic
Disorders Clinical Trials 14
Clinical
Trials by Phase in G7 Countries 15
Clinical
Trials in G7 Countries by Trial Status 16
Clinical
Trials by E7 Countries: Proportion of Hyperlipidemia to Metabolic
Disorders Clinical Trials 17
Clinical
Trials by Phase in E7 Countries 18
Clinical
Trials in E7 Countries by Trial Status 19
Clinical
Trials by Phase 20
In
Progress Trials by Phase 21
Clinical
Trials by Trial Status 22
Clinical
Trials by End Point Status 23
Subjects
Recruited Over a Period of Time 24
Clinical
Trials by Sponsor Type 25
Prominent
Sponsors 26
Top
Companies Participating in Hyperlipidemia Therapeutics Clinical
Trials 27
Prominent
Drugs 28
Latest
Clinical Trials News on Hyperlipidemia 29
May
23, 2016: BioRestorative Therapies Announces Promising Data to
Advance its Program for the Treatment of Metabolic Disorders 29
Apr
04, 2016: New study results of Repatha (evolocumab) in
statin-intolerant patients published in Journal of the American
Medical Association 29
Apr
03, 2016: Positive Efficacy And Tolerability Study Of Repatha
(evolocumab) In Statin-Intolerant Patients Published In "Journal
of the American Medical Association" 30
Apr
01, 2016: Pfizer Announces Positive Topline Results From Second Phase
3 Lipid-Lowering Study Evaluating Bococizumab 30
Mar
21, 2016: Amgen To Present Repatha (Evolocumab) Data At ACC.16 31
Clinical
Trial Profile Snapshots 33
Appendix
601
Abbreviations
601
Definitions
601
Research
Methodology 602
Secondary
Research 602
About
GlobalData 603
Contact
Us 603
Disclaimer
603
Source
604
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment